{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:58:43Z","timestamp":1759960723543},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/aps.2017.94","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T11:00:42Z","timestamp":1511434842000},"page":"923-929","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels"],"prefix":"10.1038","volume":"39","author":[{"given":"Yan-hong","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-feng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"BFaps201794_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Hegedus L . Graves' Disease. N Engl J Med 2016; 375: 1552\u201365.","journal-title":"N Engl J Med"},{"key":"BFaps201794_CR2","doi-asserted-by":"publisher","first-page":"9697849","DOI":"10.1155\/2016\/9697849","volume":"2016","author":"DM Smith","year":"2016","unstructured":"Smith DM, Dutta S, Ahmed F, Thaha MA . Change in practice over four decades in the management of Graves' disease in Scotland. J Thyroid Res 2016; 2016: 9697849.","journal-title":"J Thyroid Res"},{"key":"BFaps201794_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2337\/diab.18.9.633","volume":"18","author":"JW Doar","year":"1969","unstructured":"Doar JW, Stamp TC, Wynn V, Audhya TK . Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes 1969; 18: 633\u20139.","journal-title":"Diabetes"},{"key":"BFaps201794_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1210\/jcem-51-3-478","volume":"51","author":"UM Kabadi","year":"1980","unstructured":"Kabadi UM, Eisenstein AB . Impaired pancreatic alpha-cell response in hyperthyroidism. J Clin Endocrinol Metab 1980; 51: 478\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFaps201794_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/0026-0495(86)90242-8","volume":"35","author":"P Cohen","year":"1986","unstructured":"Cohen P, Barzilai N, Barzilai D, Karnieli E . Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients. Metabolism 1986; 35: 744\u20139.","journal-title":"Metabolism"},{"key":"BFaps201794_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1210\/jcem-66-3-565","volume":"66","author":"DC Shen","year":"1988","unstructured":"Shen DC, Davidson MB, Kuo SW, Sheu WH . Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab 1988; 66: 565\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFaps201794_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2169\/internalmedicine.34.339","volume":"34","author":"S Ohguni","year":"1995","unstructured":"Ohguni S, Notsu K, Kato Y . Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med 1995; 34: 339\u201341.","journal-title":"Intern Med"},{"key":"BFaps201794_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2174\/157016111304150722171221","volume":"13","author":"Z Wang","year":"2015","unstructured":"Wang Z, Duan DD, Wang YY . Editorial: combination therapy of vascular diseases and fangjiomics: when west meets east in the era of phenomics. Curr Vasc Pharmacol 2015; 13: 420\u20132.","journal-title":"Curr Vasc Pharmacol"},{"key":"BFaps201794_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/aps.2015.33","volume":"36","author":"DD Duan","year":"2015","unstructured":"Duan DD, Wang Z, Zhang BL, Wang YY . Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine. Acta Pharmacol Sin 2015; 36: 651\u20133.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201794_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/aps.2014.125","volume":"36","author":"J Liu","year":"2015","unstructured":"Liu J, Wang Z . Diverse array-designed modes of combination therapies in Fangjiomics. Acta Pharmacol Sin 2015; 36: 680\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201794_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/0091270010382913","volume":"51","author":"Z Wang","year":"2011","unstructured":"Wang Z, Liu J, Cheng Y, Wang Y . Fangjiomics: in search of effective and safe combination therapies. J Clin Pharmacol 2011; 51: 1132\u201351.","journal-title":"J Clin Pharmacol"},{"key":"BFaps201794_CR12","first-page":"E1014","volume":"273","author":"JE Friedman","year":"1997","unstructured":"Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol 1997; 273: E1014\u201323.","journal-title":"Am J Physiol"},{"key":"BFaps201794_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/aps.2014.138","volume":"36","author":"ZZ Yang","year":"2015","unstructured":"Yang ZZ, Liu W, Zhang F, Li Z, Cheng YY . Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach. Acta Pharmacol Sin 2015; 36: 699\u2013707.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201794_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0954-6820.1986.tb02724.x","volume":"22","author":"B Ahren","year":"1986","unstructured":"Ahren B . Hyperthyroidism and glucose intolerance. Acta Med Scandinav 1986; 22: 5\u201314.","journal-title":"Acta Med Scandinav"},{"key":"BFaps201794_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1113\/jphysiol.1963.sp007294","volume":"169","author":"RJ Levin","year":"1963","unstructured":"Levin RJ, Smyth DH . The effect of the thyroid gland on intestinal absorption of hexoses. J Physiol 1963; 169: 755\u201369.","journal-title":"J Physiol"},{"key":"BFaps201794_CR16","first-page":"159","volume":"82","author":"L Hellstrom","year":"1997","unstructured":"Hellstrom L, Wahrenberg H, Reynisdottir S, Arner P . Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 159\u201366.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFaps201794_CR17","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1172\/JCI105640","volume":"46","author":"M Vaughan","year":"1967","unstructured":"Vaughan M . An in vitro effect of triiodothyronine on rat adipose tissue. J Clin Invest 1967; 46: 1482\u201391.","journal-title":"J Clin Invest"},{"key":"BFaps201794_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1210\/jc.2005-0960","volume":"91","author":"G Dimitriadis","year":"2006","unstructured":"Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, et al. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 2006; 91: 1112\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFaps201794_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2337\/diacare.23.2.248","volume":"23","author":"ZT Bloomgarden","year":"2000","unstructured":"Bloomgarden ZT . American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes. Diabetes Care 2000; 23: 248\u201352.","journal-title":"Diabetes Care"},{"key":"BFaps201794_CR20","first-page":"12","volume":"10","author":"XP Huang","year":"2003","unstructured":"Huang XP, Yuan ZK, Lu FG, Xie MZ, Hu ZX, Yao XL . Effects of Yangxin Tongmai Tablets on erythrocyte membrane of insulin resistance syndrome. Chin J Information Tradit Chin Med 2003; 10: 12\u20134","journal-title":"Chin J Information Tradit Chin Med"},{"key":"BFaps201794_CR21","first-page":"220","volume":"2","author":"XP Huang","year":"2004","unstructured":"Huang XP, Yuan ZK, Lu FG . Tian Song, Xie MZ, Wang DS, et al. Effects of Yangxin Tongmai Tablet on rythrocyte insulin receptor of insulin resistance syndrome in rats. Chin J Cardiovasc Rev 2004; 2: 220\u20133.","journal-title":"Chin J Cardiovasc Rev"},{"key":"BFaps201794_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3736\/jcim20030406","volume":"1","author":"ZX Hu","year":"2003","unstructured":"Hu ZX, Yuan ZK, Huang XP, Lu FG, Xie MZ . An experimental study on Yangxin tongmai tablet to insulin resistance syndrome in rats, hemorheology and insulin sensitivity. Chin J Integr Med Cardio-\/Cerebrovasc Dis 2003; 1: 255\u20137.","journal-title":"Chin J Integr Med Cardio-\/Cerebrovasc Dis"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201794","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.94","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps201794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T23:54:39Z","timestamp":1719618879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["BFaps201794"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.94","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"assertion":[{"value":"8 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}